Indacterol derivatives and phosphodiesterase inhibitors for the treatment of airway diseases

Details for Australian Patent Application No. 2006254318 (hide)

Owner Novartis AG

Inventors Trifilieff, Alexandre

Agent Davies Collison Cave

Pub. Number AU-A-2006254318

PCT Pub. Number WO2006/128675

Priority 0511066.3 31.05.05 GB

Filing date 30 May 2006

Wipo publication date 7 December 2006

International Classifications

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/128675 Priority application(s): WO2006/128675

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254328-Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions

2006254317-Combinations of indacaterol derivatives and other agents for the treatment of airway diseases